In the news, making news.
The latest from Teal Health — product, partnerships, research, and regulatory milestones — and where our work is showing up in the press.
As featured in
Making news in women’s preventive health
Featured
Teal Health Raises $22 Million Series A to Expand Access to the Most Accurate FDA-Authorized At-Home HPV Cervical Cancer Screening
Round Led by .406 Ventures Fuels Teal Health’s Next Phase of Growth, Expanding Payor, Health System, Employer and Provider Partnerships Ahead of Broad Insurance Coverage in 2027.
Teal Health is Awarded $1.68 Million SBIR Grant from National Cancer Institute (NCI) of the National Institutes of Health (NIH) for At-Home Cervical Cancer Screening
Teal Health Completes Clinical Trial at Record Speed and Receives FDA Breakthrough Designation for Its At-Home Cervical Cancer Screening Device, the Teal Wand™
In the last 6 months, Teal Health and their clinical study partners exceeded their study enrollment numbers months ahead of schedule, produced strong clinical performance data, and was granted FDA Breakthrough status to help accelerate the review of their self-collect cervical cancer screening device.
Teal Health Partners with Leading Health Organizations in a Nationwide Clinical Trial for their Self-Collect Device for Cervical Cancer Screening, the Teal Wand™
Teal Health’s revolutionary access-anywhere self-collect cervical cancer screening is tracking towards FDA submission and market availability.